What is Pipeline Rx?
Pipeline Rx specializes in delivering comprehensive pharmacy and telepharmacy services tailored for community hospitals, multi-facility health systems, and specialized healthcare facilities. Their service portfolio encompasses clinical telepharmacy, transitions of care management, and advanced patient therapy management systems. By integrating technology with deep industry expertise, Pipeline Rx aims to optimize pharmacy operations, improve patient outcomes, and drive cost efficiencies across various care settings, including surgery centers and long-term care facilities. The company's focus on seamless medication management positions it as a key player in the healthcare technology sector.
How much funding has Pipeline Rx raised?
Pipeline Rx has raised a total of $18.6M across 4 funding rounds:
Private Equity
$2.4M
Other Financing Round
$5M
Private Equity
$9.2M
Debt
$2M
Private Equity (2014): $2.4M with participation from AMN Healthcare Services
Other Financing Round (2014): $5M led by AMN Healthcare
Private Equity (2015): $9.2M supported by McKesson, AMN Healthcare, and Mitsui & Co. (U.S.A.), Inc.
Debt (2020): $2M featuring PPP
Key Investors in Pipeline Rx
AMN Healthcare
AMN Healthcare is a leading provider of total talent solutions for healthcare organizations, specializing in staffing and recruitment. Their investment in Pipeline Rx suggests a strategic interest in expanding their healthcare services portfolio.
McKesson
McKesson is a major global healthcare company involved in the distribution of pharmaceuticals and medical supplies, as well as providing technology solutions. Their participation indicates a focus on integrated pharmacy management and healthcare technology.
Mitsui & Co. (U.S.A.), Inc.
Mitsui & Co. is a global trading and investment company with a diverse portfolio. Their investment in Pipeline Rx highlights an interest in healthcare solutions and the potential for global expansion of pharmacy services.
What's next for Pipeline Rx?
The substantial enterprise-level funding and recent strategic investment signal a strong growth trajectory for Pipeline Rx. This capital infusion is likely to accelerate the development and deployment of their innovative telepharmacy solutions, potentially expanding their market reach into new healthcare segments or geographical regions. The company may also focus on enhancing its existing platforms for clinical telepharmacy and patient therapy management, further solidifying its competitive advantage. Strategic partnerships and acquisitions could also be on the horizon as Pipeline Rx leverages its enhanced financial standing to consolidate its position in the healthcare technology market.
See full Pipeline Rx company page
